RACB

Research Alliance Corp. II [RACB] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

RACB Stock Summary

In the News

RACB Financial details

Company Rating
-
Market Cap
0
Income
1.79M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
22.06
Forward P/E
-
PEG
-
P/S
-
P/B
0.29
P/C
-
P/FCF
-
Quick Ratio
5.94
Current Ratio
7.31
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.09
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
355.07%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.64-10.45
52W High
+1.05%
52W Low
+12.28%
RSI
-
Rel Volume
-
Avg Volume
205.78K
Volume
5
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
0.45%
-
-
-
-
Beta
-
-
-
Volatility
0.02%, 0.02%
Prev Close
0%
Price
10.105
Change
0.45%

Something similar

Top by Market Cap
JPM
AAPL
MSFT
BRH.DE
CMC.DE
Same Sector
ZPDU.DE
NQP
SC00.DE
305540.KS
BBP
Check Those
PTR
CABA
INR
002795.KS
BP3L.L
Similar Market Cap
FIVG
MCMVX
018880.KS
003029.SZ
BIOGAS.ST

Company Profile

Financial Services Shell Companies

Research Alliance Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector. Research Alliance Corp. II was incorporated in 2020 and is based in Las Vegas, Nevada.